Power Law company profile

Bebetter Med

Biotech & Life Sciences · Guangzhou, China · Founded 2012 · IPO 2025 Unicorn

Operates as a pharmaceutical research and development enterprise with a focus on small molecule oncology drugs

Valuation

$1.10B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

2 investors on Bebetter Med's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Yingke Capital

Lucky Source Funds

Global footprint

Where Bebetter Med has talent and traffic

Workforce by country

1 countries with
team presence

🇨🇳 China100%

1 country shown

Web traffic by country

450 monthly visits
across markets

🇹🇼 Taiwan111.1%

Top 1 markets shown

Market sentiment

What the market is saying about Bebetter Med

An AI-synthesized read of the highest-engagement posts about Bebetter Med on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bebetter Med on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles